Evolent Health
EVH
Evolent Health (EVH) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $6.00 from $5.00 | Aug 18, 2026 |
| TD Cowen | Maintained | Buy | $6.00 from $5.00 | Aug 17, 2026 |
| Truist Securities | Maintained | Hold | $6.00 from $7.00 | Aug 12, 2026 |
| Citigroup | Upgraded | Neutral → Buy | $6.00 from $6.75 | Aug 11, 2026 |
| Canaccord Genuity | Maintained | Buy | $6.00 from $7.00 | Aug 10, 2026 |
| TD Cowen | Maintained | Buy | $5.00 from $8.00 | Jul 28, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $6.75 from $5.50 | Jul 23, 2026 |
| Canaccord Genuity | Maintained | Buy | $7.00 from $6.00 | Jul 21, 2026 |
| Truist Securities | Downgraded | Buy → Hold | $7.00 | Jun 30, 2026 |
| Truist Securities | Maintained | Buy | $7.00 from $6.00 | Jun 12, 2026 |
| Citigroup | Maintained | Buy | $5.50 from $4.00 | May 15, 2026 |
| Canaccord Genuity | Maintained | Buy | $6.00 from $4.00 | May 12, 2026 |
| Needham | Maintained | Buy | $5.00 from $4.00 | May 7, 2026 |
| Oppenheimer | Maintained | Outperform | $6.00 from $12.00 | Mar 2, 2026 |
| Truist Securities | Maintained | Buy | $6.00 from $10.00 | Feb 26, 2026 |
| UBS | Maintained | Buy | $5.00 from $10.00 | Feb 26, 2026 |
| Citigroup | Maintained | Buy | $4.00 from $6.00 | Feb 26, 2026 |
| BTIG | Maintained | Buy | $8.00 from $10.00 | Feb 25, 2026 |
| Keybanc | Downgraded | Overweight → Sector Weight | — | Feb 25, 2026 |
| RBC Capital | Maintained | Sector Perform | $3.00 from $5.00 | Feb 25, 2026 |
Frequently asked questions
What is the latest analyst rating on EVH?
On Aug 18, 2026, JP Morgan maintained Evolent Health at Overweight with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.